|
CSL BEHRING
Patient Assistance Program
Patient assistance programs (PAPs) are programs created by drug companies,
such as CSL BEHRING, to offer free or low cost drugs to individuals who are unable to
pay for their medication. These Programs may also be called indigent drug programs,
charitable drug programs or medication assistance programs. Most of the best known and
most prescribed drugs can be found in these programs. All of the major drug companies
have patient assistance programs, although every company has different eligibility and
application requirements.
The CSL BEHRING patient assistance program offers free medication to people
who otherwise cannot afford their medications. Patients must meet financial and other
program specific criteria to be eligible for assistance.
To find out how to apply for medication assistance from the CSL BEHRING patient
assistance program, visit our Patient Center and use our Database to search for the medication needed.
For a complete listing of CSL BEHRING medications available through
their patient assistance programs, see below:
CSL Behring Patient Assistance & Support Programs
|
| |
The medications available through this program are:
|
| |
| Afstyla
(antihemophilic factor (recombinant)) |
|
| |
| Berinert
(c1 esterase inhibitor) |
|
| |
| Haegarda
(C1 esterase inhibitor human injection; subcutaneous) |
|
| |
| Hemgenix
(etranacogene dezaparvovec-drlb injection) |
|
| |
| Hizentra vial 20%
(immune globulin subcutaneous (human)) |
|
| |
| Humate-P
(antihemophilic factor/von willebrand factor complex (Human)) |
|
| |
| Idelvion
(coagulation factor IX (recombinant), albumin fusion protein ) |
|
| |
| Mononine
(Coagulation Factor IX (Human) Monoclonal Antibody Purified) |
|
| |
| Privigen vial 10%
(immune globulin intravenous (human)) |
|
| |
| RiaSTAP
(fibrinogen concentrate (human)) |
|
| |
| Zemaira
(Alpha1-Proteinase Inhibitor (Human)) |
|
|
|
|
